Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression

Oncogene

Volumn 19, Issue 4, 2000, Pages 514-525

  Reichert, Torsten E ^a   Nagashima, Shigeki ^a   Kashii, Yoshiro ^a   Stanson, Joanna ^a   Gao, Gui ^b   Dou, Qing Ping ^b   Whiteside, Theresa L ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Antisense oligonucleotide; Cell cycle; Human carcinoma; IL 2 expression; p27

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIN DEPENDENT KINASE INHIBITOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; PROTEIN P21; PROTEIN P27;

ARTICLE; CANCER CELL CULTURE; CARCINOMA; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; METAPHASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034719334     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203391     Document Type: Article

References (44)

1. Alberts B, Bray D, Lewis J, Raff M, Roberts K and Watson JD. (1994). The Mechanics of Cell Division. In: Alberts B, Bray D, Lewis J, Raff M, Roberts K and Watson JD (eds). Molecular Biology of the Cell, 3rd edition, New York: Garland Publishing, Inc., pp. 911-946.
2. Alileche A, Plaisance S, Han DS, Rubinstein, E, Mingari C, Bellomo R, Jasmin C and Azzarone B. (1993). Oncogene, 8, 1791-1796.
3. Alileche A, Han D, Plaisance S, Assier E, Sahraoui Y, Clemanceau C, Metivier D, Brouty-Boyer D, Jasmin C and Azzarone B. (1994). Int. Immunol., 6, 1585-1591.
4. Arzt E, Stelzer G, Renner U, Lange M, Muller OA and Stalla GK. (1992). J. Clin. Invest., 90, 1944-1951.
5. Bouaboula M, Legoux P, Pessegue B, Delpech B, Dumont X, Piechaczyk M, Casellas P and Shire D. (1992). J. Biol. Chem., 267, 21830-21838.
6. Chen K, Demetris AJ, Van Thiel DH and Whiteside TL. (1987). Lab. Invest., 56, 114-119.
7. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
8. Ciacci C, Mahida YR, Dignass A, Koizumi M and Podolsky DK. (1993). J. Clin. Invest., 92, 527-532.
9. Duprez V, Cornet V and Dautry-Versat A. (1988). J. Biol. Chem., 263, 12860-12865.
10. Hatakeyama M and Taniguchi T. (1990). Interleukin-2. In: Sporn MB and Roberts AB (eds). Peptide Growth Factors and Their Receptors 1. New York: Springer-Verlag, pp. 523.
11. Hemar A, Lieb M, Subtil A, DiSanto JP and Dautry-Varsat A. (1994). Eur. J. Immunol., 24, 1951-1955.
12. Heo DS, Snyderman C, Gollin SM, Pan S, Walker E, Deka R, Barnes EL, Johnson JT, Herberman RB and Whiteside TL. (1989). Cancer Res., 49, 5167-5175.
13. Huberman JA. (1981). Cell, 23, 647-648.
14. Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G and Whiteside TL. (1996). Clin. Cancer Res., 2, 161-173.
15. Lin WC, Yasumura S, Suminami Y, Sung MW, Nagashima S, Stanson J and Whiteside TL. (1995). J. Immunol., 155, 4805-4816.
16. Liu J, Flanagan M, Drazba JA, Estes ML, Barnett GH, Haqqi T, Kondo S, Barna BP. (1997). J. Immunol., 159, 812-819.
17. McMillan DN, Kernohan NM, Flett ME, Heys SD, Deehan DJ, Sewell HF, Walker F and Eremin O. (1995). Int. J. Cancer., 60, 766-772.
18. Miyazaki M, Ohashi R, Tsuji T, Mihara L, Gohda E, Namba M. (1998). BBRC, 246, 873-880.
19. Nakanishi K, Hirose S, Yoshimoto T, Ishizashi H, Hiroishi K, Tanaka T, Kono T, Miyasaka M, Taniguchi T and Higashino K. (1992). Proc. Natl. Acad. Sci. USA, 89, 3551-3555.
20. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee M-H, Massaque J, Crabtree GR, Roberts JM. (1994). Nature, 382, 570-573.
21. O'Connor PM and Jackman J. (1995). Synchronization of mammalian cells. In: Paano M (ed.). Cell Cycle-Materials and Methods. Berlin Heidelberg: Springer-Verlag, pp. 63-74.
22. Pardee AB. (1989). Science, 246, 603-608.
23. Plaisance S, Rubinstein E, Alileche A, Sahraouri Y, Krief P, Augrey-Bourget Y, Jasmin C, Suarez H, Azzarone B. (1992). Int. Immunol., 4, 739-746.
24. Plaisance S, Rubinstein E, Alileche A, Benoit P, Jasmin C and Azzarone B. (1993). Int. Immunol., 5, 843-848.
25. Rabinowich H, Vitolo D, Altarac S, Herberman RB and Whiteside TL. (1992). J. Immunol., 149, 340-349.
26. Ralph P, Jeong G, Welte K, Mertelsmann R, Rabin H, Henderson LE, Souza LM, Boone TC and Robb RL. (1984). J. Immunol., 133, 2442-2445.
27. Reichert TE, Watkins S, Stanson J, Johnson JT, Whiteside TL. (1998). J. Histochem. Cytochem., 46, 603-611.
28. Reichert TE, Kashii Y, Stanson J, Zeevi A, Whiteside TL. (1999). Br. J. Cancer., 81, 822-831.
29. Rimoldi D, Salvi S, Hartmann F, Schreyer M, Blum S, Zografos L, Plaisance S, Azzarone B and Carrel S. (1993). Anticancer Res., 13, 555-564.
30. Robb RJ, Greene WC and Rusk CM. (1984). J. Exp. Med., 160, 1126-1146.
31. Sander B, Anderson J and Andersson U. (1991). Immunol. Rev., 119, 65-93.
32. Saneto RP, Altman A, Knobler RL, Johnson HM and DeVellis Y. (1986). Proc. Natl. Acad. Sci. USA, 83, 9221-9225.
33. Seigel LJ, Harper ME, Wong-Staal F, Gallo RC, Nash WG and SI OB. (1984). Science, 223, 175-178.
34. Shimizu Y, Weidmann E, Iwatsuki S, Herberman RB and Whiteside TL. (1991). Cancer Res., 51, 6153-6162.
35. Stern JB and Smith KA. (1986). Science, 233, 203-206.
36. Suminami Y, Elder EM, Lotze MT, Whiteside TL. (1995). J. Immunother., 17, 238-248.
37. Suminami Y, Kashii Y, Law JC, Lin W-C, Stanson J, Reichert TE, Rabinowich H, Whiteside TL. (1998). Oncogene, 16, 1309-1317.
38. Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M and Sugamura K. (1992). Science, 257, 379-382.
39. Takeshita T, Goto Y, Tada K, Nagata K, Asao H and Sugamura K. (1989). J. Exp. Med., 169, 1323-1332.
40. Taniguchi T and Minami Y. (1993). Cell, 73, 5-8.
41. Waldmann TA. (1991). J. Biol. Chem., 266, 2681.
42. Weidmann E, Sacchi M, Plaisance S, Heo DS, Yasumura S, Lin WC, Johnson JT, Herberman RB, Azzarone B and Whiteside TL. (1992). Cancer Res., 52, 5963-5970.
43. Whiteside TL and Herberman RB. (1995). Curr. Opin. Immunol., 7, 704-710.
44. Yasumura S, Lin WC, Weidmann E, Hebda P and Whiteside TL. (1994). Int. J. Cancer, 59, 225-234.